Efficacy and Safety of TACE Combined With Lenvatinib Plus PD-1 Inhibitors Compared With TACE Alone for Unresectable Hepatocellular Carcinoma Patients: A Prospective Cohort Study

PurposeTo compare the efficacy and safety of the combination of transcatheter arterial chemoembolization (TACE), Lenvatinib, and programmed cell death protein-1 (PD-1) inhibitors (combination group) with TACE (TACE group) in the treatment of patients with unresectable hepatocellular carcinoma (uHCC)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shuping Qu, Xiaobing Zhang, Yutian Wu, Yan Meng, Hongyu Pan, Qiang Fang, Lei Hu, Jin Zhang, Ruoyu Wang, Lixin Wei, Dong Wu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-04-01
Colecção:Frontiers in Oncology
Assuntos:
hepatocellular carcinoma
transcatheter arterial chemoembolization
lenvatinib
programmed cell death-1 inhibitor
neutrophil-to-lymphocyte ratio
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2022.874473/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados